This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy Manufacturing & Commercialization Europe

Speaking Proposals Due 17th May

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
Save the Date: 2-4 December 2024
Convention Centre DublinDublin, Ireland

Margit Holzer, Ph.D.
Scientific Director at Ulysse Consult S.a.r.L
Speaker

Agenda Sessions

  • Relevant Regulatory Background in the Field of CGT and QbD/Quality by Design (QbD) Concept and Approaches

    09:00
  • Risk Management Methodologies and Practical Considerations

    11:00
  • Stages in Process Development

    13:30
  • Process Characterisation

    14:15
  • Process Development Gene Therapy & Cell Therapy – Typical Studies and Specific Requirements

    15:30
  • Wrap up & Feedback

    16:15

At this event